FIELD: medicine; therapy.
SUBSTANCE: present invention relates to treatment of diseases associated with VDR receptor activity. That is ensured by administering an effective amount of a pharmaceutical formulation containing nanoparticles of policosanol, an inverse agonist of the vitamin D receptor.
EFFECT: this provides effective treatment with no side effects, particularly hypercalcemia.
7 cl, 15 dwg, 1 tbl, 5 ex
